Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial

Diabetologia
Kimberly J NahonPatrick C N Rensen

Abstract

The aim of this study was to evaluate the effect of sitagliptin on glucose tolerance, plasma lipids, energy expenditure and metabolism of brown adipose tissue (BAT), white adipose tissue (WAT) and skeletal muscle in overweight individuals with prediabetes (impaired glucose tolerance and/or impaired fasting glucose). We performed a randomised, double-blinded, placebo-controlled trial in 30 overweight, Europid men (age 45.9 ± 6.2 years; BMI 28.8 ± 2.3 kg/m2) with prediabetes in the Leiden University Medical Center and the Alrijne Hospital between March 2015 and September 2016. Participants were initially randomly allocated to receive sitagliptin (100 mg/day) (n = 15) or placebo (n = 15) for 12 weeks, using a randomisation list that was set up by an unblinded pharmacist. All people involved in the study as well as participants were blinded to group assignment. Two participants withdrew from the study prior to completion (both in the sitagliptin group) and were subsequently replaced with two new participants that were allocated to the same treatment. Before and after treatment, fasting venous blood samples and skeletal muscle biopsies were obtained, OGTT was performed and body composition, resting energy expenditure and [18F] fluor...Continue Reading

Associated Clinical Trials

Nov 19, 2014·Ingrid Jazet

References

Jan 27, 1990·BMJ : British Medical Journal·J N MatthewsP Royston
Oct 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yasutomi KameiAkira Kakizuka
Dec 6, 2005·Diabetes Research and Clinical Practice·Andrea TuraGiovanni Pacini
Aug 11, 2006·Current Diabetes Reports·Juris J Meier, Michael A Nauck
Mar 1, 2007·Diabetes Care·David M NathanUNKNOWN American Diabetes Association
Dec 17, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·R RetnakaranJ K Hamilton
Jul 8, 2010·American Journal of Physiology. Endocrinology and Metabolism·Paul LeeMichael J Fulham
Dec 9, 2010·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Heather A JaceneRichard L Wahl
Jan 5, 2012·Advances in Therapy·Matteo MonamiEdoardo Mannucci
Jan 25, 2012·The Journal of Clinical Investigation·Véronique OuelletAndré C Carpentier
Aug 14, 2013·European Journal of Endocrinology·Leontine E H BakkerIngrid M Jazet
Nov 12, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M MatsushitaM Saito
Mar 29, 2014·The Annals of Pharmacotherapy·Jeremy L JohnsonMinhye K Kim
Nov 22, 2014·Diabetes Care·William T CefaluRobert E Ratner
Feb 15, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sébastien M LabbéDenis Richard
Feb 19, 2015·Circulation. Cardiovascular Genetics·Pasi SoininenMika Ala-Korpela
Mar 11, 2015·Nature Communications·Jimmy F P BerbéePatrick C N Rensen
Aug 6, 2015·Cell Metabolism·Labros S SidossisDavid N Herndon
Oct 10, 2015·The Journal of Endocrinology·Amy Warner, Jens Mittag
Jan 1, 2016·Diabetes·Mark J W HanssenWouter D van Marken Lichtenbelt

❮ Previous
Next ❯

Citations

Jan 22, 2021·Andrologia·Gulnur KizilayYeter Topcu-Tarladacalisir
Dec 31, 2019·Metabolism: Clinical and Experimental·Rodolfo Guardado-MendozaAlberto Aguilar-García
Feb 24, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Amel RezkiPaul Valensi
Apr 21, 2019·Journal of Diabetes and Its Complications·Mohammed E Al-SofianiRita R Kalyani

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
nuclear magnetic resonance
biopsy
ELISA
NMR
PCR

Software Mentioned

Fiji ImageJ
Bio
Rad
SPSS Statistics

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.